(Q57098008)

2

0 references

Ying Zhang

3

0 references

Xian Huang

4

0 references

Yi Liu

5

0 references

Da-Peng Ding

6

0 references

Wei Wang

7

0 references

K Arparkorn

Breast Cancer Research and Treatment

8

0 references

language of work or name

English

0 references

publication date

November 2011

0 references

published in

0 references

volume

130

0 references

page(s)

517-29

0 references

issue

2

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s10549-011-1583-2

0 references

cites work

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Estimating the world cancer burden: Globocan 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Estrogen carcinogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Understanding breast cancer risk -- where do we stand in 2005?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Decision making by p53: life, death and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

p53: guardian AND suppressor of longevity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

p53 polymorphisms and haplotypes in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Evidence against involvement of p53 polymorphism in breast cancer predisposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

The R72P P53 mutation is associated with familial breast cancer in Jewish women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Genetic variation in TP53 and risk of breast cancer in a population-based case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Association between common variation in 120 candidate genes and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

TP53 codon 72 polymorphism and breast cancer in northern Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

TP53 mutations and Arg72Pro polymorphism in breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

How should meta-regression analyses be undertaken and interpreted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

p53 Mutations, Polymorphisms, and Haplotypes in Pakistani Ethnic Groups and Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2

p53 polymorphism and risk of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1583-2